Richard Condon, CEO Aspire Pharma, discusses successful leadership
Leading lights
Related Posts
Lab-grown lung cancer cells show potential to revolutionise treatment
The model could lead to more targeted treatments for the disease Cancer Research scientists have developed a new cell-based model of lung squamous cell carcinoma […]
New UCL-developed immunotherapy shows promising results in treating bone cancer
Bone cancer affects more than 150,000 people in the UK and is often resistant to chemotherapy A new type of immunotherapy developed by researchers from […]
PhaSER Biomedical receives $2.3m drug discovery grant from the Gates Foundation
Every year, tuberculosis, malaria and HIV cause over five million deaths worldwide PhaSER Biomedical has received a grant from the Bill & Melinda Gates Foundation […]